The link between total work performed above critical power (CP) and peripheral muscle fatigue during self-paced exercise is unknown. We investigated the influence of caffeine on the total work done above CP during a 4-km cycling time trial (TT), and the subsequent consequence on the development of central and peripheral fatigue. Nine cyclists performed three constant-load exercise trials to determine CP and two 4-km TT ~75 min after oral caffeine (5 mg·kg^-1) or cellulose (placebo) ingestion. Neuromuscular functions were assessed before and 50 min after supplementation, and 1 min after TT. Oral supplementation alone had no effect on neuromuscular function (P>0.05). Compared to placebo, caffeine increased mean power output (~4%, P=0.01) and muscle recruitment (as inferred by EMG, ~17%, P=0.01), and reduced the time to complete the TT (~2%, P=0.01). Work performed above CP during the caffeine trial (16.7{plus minus}2.1 kJ) was significantly higher than during the placebo (14.7{plus minus}2.1 kJ, P=0.01). End-exercise decline in quadriceps twitch force (pre- to post-exercise decrease in twitch force at 1 and 10 Hz) was more pronounced after caffeine compared to placebo (121{plus minus}13 and 137{plus minus}14 N vs 146{plus minus}13 and 156{plus minus}11 N; P<0.05). There was no effect of caffeine on central fatigue. In conclusion, caffeine increases muscle recruitment which enables greater work performed above CP and higher end-exercise peripheral locomotor muscle fatigue.

The aim of this study was to perform a systematic review on the effects of caffeine mouth rinsing on physical and cognitive performance. Following a search through 4 databases, 18 studies were found meeting the inclusion criteria (15 for physical performance and 3 for cognitive performance). All selected studies found an improvement in cognitive performance with caffeine mouth rinse. Four studies found positive effects of caffeine mouthwash on physical performance when repeated during exercise, while one study detected a positive effect with a single mouthwash before exercise, but only in a fasted state. Among these studies that showed positive effects, however, three (2 for physical performance and 1 for cognitive performance) presented fair methodological quality. There was also a variety of methodological approaches in the studies that showed no improvement in physical performance with caffeine mouth rinse, which may have influenced the potential to detect the ergogenic effect of caffeine mouth rinse. Thus, the effects of caffeine mouth rinse on physical performance are mixed, but a potential ergogenic effect might be present in a fasted state and when mouthwash is repeated during exercise. Concerning cognitive performance, caffeine mouth rinse seems to be a beneficial strategy.

We examined the effect of acute and chronic sprint interval training (SIT), with or without prior caffeine intake, on levels of exercise-induced inflammatory plasma cytokines [interleukin (IL)-6, IL-10, tumor necrosis factor (TNF)-α]. Twenty physically-active men ingested either a placebo (n = 10) or caffeine (n = 10) 1 h before each SIT session(13-s × 30-s sprint/15 s of rest) during six training sessions (2 weeks). The early (before, immediately after, and 45 min after the exercise) and late (24 and 48 h after the exercise) cytokine and creatine kinase (CK) responses were analyzed for the first and last training sessions. Plasma IL-6 and IL-10 peaked 45 min after the exercise, and then returned to basal values within 24 h (p < 0.05) in both groups on both occasions (p > 0.05). On both occasions, and for both groups, plasma TNF-α increased from rest to immediately after the exercise and then decreased at 45 min before reaching values at or below basal levels 48 h after the exercise (p < 0.05). Serum CK increased from rest to 24 and 48 h post-exercise in the first training session (p < 0.05), but did not alter in the last training session for the PLA group (p > 0.05). Serum CK was unchanged in both the first and last training sessions for the CAF group (p > 0.05). Two weeks of SIT induced a late decrease in the IL-6/IL-10 ratio (p < 0.05) regardless of caffeine intake, suggesting an improved overall inflammatory status after training. In conclusion, a single session of SIT induces muscle damage that seems to be mitigated by caffeine intake. Two weeks of SIT improves the late SIT-induced muscle damage and inflammatory status, which seems to be independent of caffeine intake.

The influence of cyclists’ performance levels on caffeine-induced increases in neuromuscular fatigue after a 4-km cycling time trial (TT) was investigated. Nineteen cyclists performed a 4-km cycling TT 1 h after ingesting caffeine (5 mg·kg⁻¹) or placebo (cellulose). Changes from baseline to after exercise in voluntary activation (VA) and potentiated 1 Hz force twitch (Q_tw,pot) were used as markers of central and peripheral fatigue, respectively. Participants were classified as “high performing” (HP, n = 8) or “low performing” (LP, n = 8) in accordance with their performance in a placebo trial. Compared with placebo, caffeine increased the power, anaerobic mechanical power, and anaerobic work, reducing the time to complete the trial in both groups (p < 0.05). There was a group versus supplement and a group versus supplement versus trial interaction for Q_tw,pot, in which the postexercise reduction was greater after caffeine compared with placebo in the LP group (Q_tw,pot = −34% ± 17% vs. −21% ± 11%, p = 0.02) but not in the HP group (Q_tw,pot = −22% ± 8% vs. −23% ± 10%, p = 0.64). There was no effect of caffeine on VA, but there was a group versus trial interaction with lower postexercise values in the LP group than in the HP group (p = 0.03). Caffeine-induced improvement in 4-km cycling TT performance seems to come at the expense of greater locomotor muscle fatigue in LP but not in HP cyclists. Novelty Caffeine improves exercise performance at the expense of a greater end-exercise peripheral fatigue in low-performing athletes. Caffeine-induced improvement in exercise performance does not affect end-exercise peripheral fatigue in high-performing athletes. High-performing athletes seem to have augmented tolerance to central fatigue during a high-intensity time trial.

The purpose of this study was to investigate the difference between arterialized and venous blood lactate concentrations [La] during constant-load exercises at different intensities. Fifteen physically active men cycled for 30 minutes (or until exhaustion) at the first lactate threshold (LT1), at 50% of the difference between the first and second lactate threshold (TT50%), at the second lactate threshold (LT2), and at 25% of the difference between LT2 and maximal aerobic power output (TW25%). Samples of both arterialized and venous blood were collected simultaneously at rest and every 5 minutes during the exercise. The arterialized blood [La] was higher at minute 5 than venous blood [La] for all exercise intensities (p < 0.05). After this period, the arterialized and venous [La] samples became similar until the end of the exercise (p > 0.05). The arterialized-venous difference during the first 10 minutes was greater for the two highest exercise intensities (LT2 and TW25%) compared with the two lowest (LT1 and TT50%, p < 0.05). Thereafter, arterialized-venous difference decreased progressively, reaching values close to zero for all exercise intensities (p > 0.05). These results suggest a delayed lactate appearance in the venous blood, which is accentuated at higher exercise intensities. The lactate measured in arterialized and venous blood is interchangeable only when blood samples are collected at least 10 minutes after the exercise starts.

The objective of this study was to evaluate the effect of a reduced-carbohydrate (reduced-CHO) diet on the rate of perceived exertion (RPE) curve during an incremental test. Nine physically active men performed a progressive incremental test on a cycle ergometer (25 W·2 min⁻¹) after 72 hr on either a control diet (60% CHO) or a reduced-CHO diet (30% CHO). Lactate and RPE thresholds were identified using the Dmax method (DmaxLa and DmaxRPE, respectively). Power output, heart rate and RPE scores in DmaxLa and DmaxRPE were similar between the diets and were not different from each other, regardless of the diet. Lactate values were consistently higher (p < .05) in the control diet compared with the reduced-CHO diet during power output after the lactate breakpoint; however, they were not accompanied by a proportional increase in RPE scores. These results suggest that DmaxRPE and DmaxLa are not dissociated after a short-period reduced-CHO diet, whereas the lactate values after the lactate threshold are reduced with a reduced-CHO diet, although they are not accompanied by alterations in RPE.